News and Insights of 3D Printing and Manufacturing
Kijenzi, a humanitarian start-up from Pennsylvania State University’s College of Engineering, is aiding remote healthcare facilities in Kenya with 3D printed medical supplies.
Australian metal 3D printer manufacturer Aurora Labs has agreed to develop designs, specifications and parameters for the 3D printing of titanium medical implants. Developed under partnership with the University of Western Australia (UWA) and Royal Perth Hospital (RPH), the parameters will come in the form of an instructional guide for using an Aurora Labs 3D printer to manufacture medical implants.
Contract 3D printed implant manufacturer Tangible Solutions, has announced the expansion of its facility in Fairborn, Ohio.
California-headquartered medical imaging company QT Ultrasound has used its detailed pictures of microanatomy to 3D print a model of a woman’s breast tissue. A tangible model of the complex duct system, the model presents a potential avenue for diagnosticians working with breast cancer.
Swedish 3D bioprinter manufacturer CELLINK has agreed to acquire the in-vitro technology specialist MatTek Corporation for $68 million.
New York City’s Hospital for Special Surgery (HSS) and implant manufacturer, LimaCorporate unveiled the first provider-based 3D design and printing facility for custom complex joint replacement solutions.
Nexxt Spine, an Indiana-based spinal implants manufacturer, has announced that it will develop 3D printed bone healing spinal implants with the help of MTS Systems Corporation, a global manufacturer and supplier of simulations and testing systems.
Researchers from the University of Wollongong (UOW) ARC Centre of Excellence for Electromaterials Science (ACES) in Australia, have developed a customizable 3D bioprinter, 3D Alek, to combat congenital ear deformity.
UC Davis Health’s surgeons are using 3D printing to assist them in complex surgical procedures. Part of the University of California, Davis, the faculty believes that in the long term this technology will remove barriers to understanding in medical surgery and medical education.
Renishaw additive manufacturing has played a pivotal role in the recent clinical trial of an experimental treatment for Parkinson’s Disease. Documented in a two part-series produced by the BBC titled The Parkinson’s Drug Trial: A Miracle Cure? this trial includes the novel development of 3D printed medical device capable of delivering drugs directly to affected parts of the brain. After 40-80 weeks in-situ, the implants have become part of a potentially landmark advance in the treatment of this long-term degenerative disorder.